Question 1

Am I eligible for this trial based on my current health and treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Safety and Effects of Gefitinib in Triple-negative,EGFR Positive Metastatic Breast Cancer clinical trial (NCT01732276). Contact the study team or your healthcare provider for specific answers.

Question 2

How does gefitinib compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Safety and Effects of Gefitinib in Triple-negative,EGFR Positive Metastatic Breast Cancer clinical trial (NCT01732276). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from gefitinib?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Safety and Effects of Gefitinib in Triple-negative,EGFR Positive Metastatic Breast Cancer clinical trial (NCT01732276). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for visits during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Safety and Effects of Gefitinib in Triple-negative,EGFR Positive Metastatic Breast Cancer clinical trial (NCT01732276). Contact the study team or your healthcare provider for specific answers.

Question 5

What tests or monitoring will be required if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Safety and Effects of Gefitinib in Triple-negative,EGFR Positive Metastatic Breast Cancer clinical trial (NCT01732276). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects or my condition worsens?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Safety and Effects of Gefitinib in Triple-negative,EGFR Positive Metastatic Breast Cancer clinical trial (NCT01732276). Contact the study team or your healthcare provider for specific answers.

What this study is about